Skip to main content
. Author manuscript; available in PMC: 2024 May 13.
Published in final edited form as: J Environ Expo Assess. 2023 Oct 29;2(4):22. doi: 10.20517/jeea.2023.27

Table 3.

Concentrations (in pg/mL) of different proteins in the BALF of mice exposed to towels with e-cig aerosols compared to control mice exposed to towels with no e-cig aerosols (ENDS-contaminated vs. control)

BALF Proteins
Protein Exposed Control P value (all exposed vs. all control)
all exposed mice (n = 7) Males (n = 5) Females (n = 2) 48 days (n = 3) 75 days (n = 4) all control mice (n = 6) Males (n = 4) Females (n = 2) 48 days (n = 2) 75 days (n = 4)
GM-CSF NA NA NA NA NA NA NA NA NA NA NA
IFNγ 0.3 ± 0.2 0.4 ± 0.2 0.2 ± 0.2 0.5 ± 0.2 0.2 ± 0.1 0.3 ± 0.1 0.3 ± 0.1 0.3 ± 0.1 0.3 ± 0.1 0.2 ± 0.1 0.893
IL-1α 59.0 ± 19.0 67.5 ± 14.7 37.9 ± 6.9 69.0 ± 17.2 51.5 ± 18.7 62.7 ± 12.6 58.6 ± 13.6 70.9 ± 6.5 68.1 ± 13.4 60.0 ± 13.3 0.582
IL-1β 0.6 ± 0.3 0.6 ± 0.3 0.3 ± 0.3 0.7 ± 0.2 0.4 ± 0.4 0.9 ± 0.2 0.8 ± 0.2 1.0 ± 0.1 0.7 ± 0.1 0.9 ± 0.1 0.090
IL-10 1.7 ± 0.5 1.8 ± 0.5 1.5 ± 0.2 2.02 ± 0.6 1.4 ± 0.2 2.0 ± 0.4 2.1 ± 0.4 1.8 ± 0.4 2.3 ± 0.1 1.8 ± 0.4 0.225
IL-12p70 4.1 ± 1.5 4.3 ± 1.7 3.5 ± 1.0 5.04 ± 1.9 3.4 ± 0.8 5.2 ± 0.9 5.6 ± 0.8 4.4 ± 0.2 6.01 ± 1.0 4.8 ± 0.5 0.096
IL-13 8.5 ± 0.6 8.4 ± 0.7 8.6 ± 0.2 8.5 ± 1.0 8.4 ± 0.3 7.5 ± 0.4 7.4 ± 0.4 7.5 ± 0.4 7.1 ± 0.2 7.6 ± 0.3 0.006
IL-17A 0.1 ± 0.1 0.1 ± 0.1 0.1 ± NA 0.1 ± 0.1 0.1 ± 0.1 0.1 ± 0.03 0.1 ± 0.03 0.0 ± NA 0.1 ± 0 0.1 ± 0.04 NA
IL-2 6.9 ± 2.7 8.0 ± 2.3 4.1 ± 0.93 9.1 ± 2.5 5.2 ± 1.4 7.0 ± 1.8 7.3 ± 2.2 6.6 ± 1.0 8.9 ± 1.7 6.1 ± 1.0 0.731
IL-4 0.1 ± 0.07 0.1 ± 0.03 0.1 ± 0.01 0.1 ± 0.03 0.1 ± 0.03 0.1 ± 0.03 0.1 ± 0.03 0.1 ± 0.04 0.1 ± 0.01 0.1 ± 0.03 0.166
IL-5 1.0 ± 0.2 1.0 ± 0.2 1.0 ± 0.05 1.0 ± 0.2 0.9 ± 0.2 1.0 ± 0.3 0.9 ± 0.3 1.2 ± 0.2 0.9 ± 0.02 1.1 ± 0.3 0.731
IL-6 1.9 ± 1.2 2.1 ± 1.3 1.6 ± 1.0 2.0 ± 1.8 1.9 ± 0.7 2.3 ± 1.8 2.7 ± 2.1 1.6 ± 0.7 3.3 ± 3.2 1.8 ± 0.9 0.718
IL-7 0.9 ± 0.4 0.9 ± 0.5 1.0 ± 0.3 1.1 ± 0.5 0.8 ± 0.3 1.3 ± 0.7 1.3 ± 0.7 1.3 ± 0.9 1.4 ± 1.2 1.3 ± 0.5 0.272
KC 4.1 ± 0.8 4.2 ± 0.9 3.8 ± 0.5 3.9 ± 0.8 4.23 ± 0.8 4.4 ± 1.5 4.9 ± 1.7 3.5 ± 0.1 4.32 ± 2.4 4.51 ± 1.3 0.766
LIX 9.2 ± 5.8 9.2 ± 5.8 NA 11.4 ± 4.5 2.4 ± NA 10.5 ± 4.8 9.2 ± 4.7 13.0 ± 5.2 5.37 ± 1.4 13.0 ± 3.3 0.582
MCP-1 11.2 ± 4.6 11.7 ± 5.0 10.1 ± 4.7 15.0 ± 1.4 8.5 ± 4.0 14.5 ± 4.5 15.9 ± 5.1 11.7 ± 0.5 19.4 ± 3.6 12.1 ± 2.3 0.218
MIP-2 84.3 ± 12.6 87.8 ± 10.8 75.7 ± 16.7 85.8 ± 14.0 83.2 ± 13.5 96.3 ± 15.3 90.6 ± 16.0 107.7 ± 4.2 87.2 ± 18.9 100.8 ± 13.7 0.175
TNFα 1.7 ± 0.3 1.7 ± 0.4 1.5 ± 0.2 1.9 ± 0.3 1.5 ± 0.2 1.7 ± 0.4 1.6 ± 0.4 1.9 ± 0.1 1.7 ± 0.6 1.7 ± 0.3 0.943

NA means protein measurements were below the limit of detection. Results are presented as mean ± standard deviation (sd) for all exposed (n = 7) and all control (n = 6) mice. Under each exposure category, mean ± sd are presented by age and sex where applicable. P values are the results of one-way ANOVA, where bolded and underlined P values are ≤ 0.05 and < 0.1, respectively. NA means not measured and/or not estimated. BALF: bronchoalveolar lavage fluid; ENDS: electronic nicotine delivery systems; ANOVA: analysis of variance.